URGN
UroGen Pharma Ltd.
NASDAQIsraelPharmaceuticals
Market capitalizationUSD 2.15BAs of 9/18/2026, 11:59:59 PM
UroGen Pharma Ltd. (URGN) is a publicly traded company listed on Nasdaq Stock Market and associated with Israel. Its latest validated market capitalization is USD 2.15B. The latest available share price is $43.25. Institution currently ranks it #5,431 globally by market capitalization. Institution classifies the company in the Pharmaceuticals industry.
Global rank#5,431
Country rank#14Israel
Share price$43.25end of day
Market capUSD 2.15B
Share price$43.25
1D change-1.59%
52-week range16.42 – 50.29
Price history
Adjusted historical share price · USDPrice history unavailableCurrent market data remains available while historical price coverage is prepared.
Company profile
TickerURGN
Primary listingNasdaq Stock Market
CountryIsrael
IndustryPharmaceuticals
Institution
Starting or running a U.S. company?
Institution coordinates incorporation, bookkeeping and tax preparation for modern businesses.